Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
9001
9002
9003
9004
9005
9006
9007
9008
9009
9010
9011
9012
9013
9014
9015
9016
9017
9018
9019
9020
9021
9022
9023
9024
9025
9026
9027
9028
9029
9030
9031
9032
9033
9034
9035
9036
9037
9038
9039
9040
9041
9042
9043
9044
9045
9046
9047
9048
9049
9050
9051
9052
9053
9054
9055
9056
9057
9058
9059
9060
9061
9062
9063
9064
9065
9066
9067
9068
9069
9070
9071
9072
9073
9074
9075
9076
9077
9078
9079
9080
9081
9082
9083
9084
9085
9086
9087
9088
9089
9090
9091
9092
9093
9094
9095
9096
9097
9098
9099
9100
9101
9102
9103
9104
9105
9106
9107
9108
9109
9110
9111
9112
9113
9114
9115
9116
9117
9118
9119
9120
9121
9122
9123
9124
9125
9126
9127
9128
9129
9130
9131
9132
9133
9134
9135
9136
9137
9138
9139
9140
9141
9142
9143
9144
9145
9146
9147
9148
9149
9150
9151
9152
9153
9154
9155
9156
9157
9158
9159
9160
9161
9162
9163
9164
9165
9166
9167
9168
9169
9170
9171
9172
9173
9174
9175
9176
9177
9178
9179
9180
9181
9182
9183
9184
9185
9186
9187
9188
9189
9190
9191
9192
9193
9194
9195
9196
9197
9198
9199
9200
| UnnamedSample_HQ_transcript/64266|m.16902 | UnnamedSample_HQ_transcript/64266 | Coverage 0.739 too low. | 3c8737d570ca9885e943834d0e789055 | 183 | Pfam | PF02469 | Fasciclin domain | 20 | 148 | 1.8E-23 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/87366|m.20849 | UnnamedSample_HQ_transcript/87366 | Identity 0.928 too low. | 0c455020ac1f9fcbc984d3867c6c220d | 444 | Pfam | PF14828 | Amnionless | 109 | 430 | 1.0E-45 | T | 22-09-2020 | IPR026112 | Amnionless |
| UnnamedSample_HQ_transcript/97475|m.22301 | UnnamedSample_HQ_transcript/97475 | Coverage 0.987 too low. | 81d3ae411a34f111d65b6bb256e5d806 | 337 | Pfam | PF02201 | SWIB/MDM2 domain | 249 | 319 | 7.1E-24 | T | 22-09-2020 | IPR003121 | SWIB/MDM2 domain |
| UnnamedSample_HQ_transcript/109294|m.23749 | UnnamedSample_HQ_transcript/109294 | Coverage 0.944 too low. | d9960b54c057a03b118434f3d9bd2787 | 231 | Pfam | PF03015 | Male sterility protein | 102 | 195 | 8.2E-29 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/57190|m.15485 | UnnamedSample_HQ_transcript/57190 | Identity 0.598 too low. | a2031aaf5f6dc9639a4fbf4ae118545a | 419 | Pfam | PF13639 | Ring finger domain | 227 | 270 | 2.6E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/57190|m.15485 | UnnamedSample_HQ_transcript/57190 | Identity 0.598 too low. | a2031aaf5f6dc9639a4fbf4ae118545a | 419 | Pfam | PF02225 | PA domain | 50 | 142 | 7.7E-8 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/7743|m.3101 | UnnamedSample_HQ_transcript/7743 | Coverage 0.972 too low. | bd1fd996d6afc43dddabb6836462f716 | 1068 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 224 | 313 | 7.7E-10 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/7743|m.3101 | UnnamedSample_HQ_transcript/7743 | Coverage 0.972 too low. | bd1fd996d6afc43dddabb6836462f716 | 1068 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 345 | 424 | 3.3E-15 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/7743|m.3101 | UnnamedSample_HQ_transcript/7743 | Coverage 0.972 too low. | bd1fd996d6afc43dddabb6836462f716 | 1068 | Pfam | PF01734 | Patatin-like phospholipase | 666 | 830 | 2.4E-20 | T | 22-09-2020 | IPR002641 | Patatin-like phospholipase domain |
| UnnamedSample_HQ_transcript/25357|m.8303 | UnnamedSample_HQ_transcript/25357 | Coverage 0.622 too low. | 15e3a93a57d857b6913320022e1f65c4 | 761 | Pfam | PF00225 | Kinesin motor domain | 66 | 394 | 5.2E-119 | T | 22-09-2020 | IPR001752 | Kinesin motor domain |
| UnnamedSample_HQ_transcript/8416|m.3327 | UnnamedSample_HQ_transcript/8416 | Coverage 0.458 too low. | 15e3a93a57d857b6913320022e1f65c4 | 761 | Pfam | PF00225 | Kinesin motor domain | 66 | 394 | 5.2E-119 | T | 22-09-2020 | IPR001752 | Kinesin motor domain |
| UnnamedSample_HQ_transcript/9866|m.3782 | UnnamedSample_HQ_transcript/9866 | Coverage 0.961 too low. | 8967a96b98d53f46c9d6aa4dab317c73 | 642 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 10 | 582 | 3.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/4939|m.2169 | UnnamedSample_HQ_transcript/4939 | Coverage 0.171 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF06009 | Laminin Domain II | 352 | 474 | 8.2E-10 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/4939|m.2169 | UnnamedSample_HQ_transcript/4939 | Coverage 0.171 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 1111 | 1237 | 1.4E-22 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/4939|m.2169 | UnnamedSample_HQ_transcript/4939 | Coverage 0.171 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 488 | 642 | 1.8E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/4939|m.2169 | UnnamedSample_HQ_transcript/4939 | Coverage 0.171 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 891 | 1010 | 3.4E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/4939|m.2169 | UnnamedSample_HQ_transcript/4939 | Coverage 0.171 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 1288 | 1415 | 5.6E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/4939|m.2169 | UnnamedSample_HQ_transcript/4939 | Coverage 0.171 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 710 | 831 | 3.4E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/2361|m.1192 | UnnamedSample_HQ_transcript/2361 | Coverage 0.144 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF06009 | Laminin Domain II | 352 | 474 | 8.2E-10 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/2361|m.1192 | UnnamedSample_HQ_transcript/2361 | Coverage 0.144 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 1111 | 1237 | 1.4E-22 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/2361|m.1192 | UnnamedSample_HQ_transcript/2361 | Coverage 0.144 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 488 | 642 | 1.8E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/2361|m.1192 | UnnamedSample_HQ_transcript/2361 | Coverage 0.144 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 891 | 1010 | 3.4E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/2361|m.1192 | UnnamedSample_HQ_transcript/2361 | Coverage 0.144 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 1288 | 1415 | 5.6E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/2361|m.1192 | UnnamedSample_HQ_transcript/2361 | Coverage 0.144 too low. | 8d83832d945e0fb0f2ee8729c018e43c | 1436 | Pfam | PF02210 | Laminin G domain | 710 | 831 | 3.4E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/87570|m.20878 | UnnamedSample_HQ_transcript/87570 | Identity 0.948 too low. | ddfcc741f95576745a92f2c7ad47dbdf | 358 | Pfam | PF18345 | Zinc finger domain | 167 | 185 | 4.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/87570|m.20878 | UnnamedSample_HQ_transcript/87570 | Identity 0.948 too low. | ddfcc741f95576745a92f2c7ad47dbdf | 358 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 236 | 289 | 1.6E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/75394|m.18918 | UnnamedSample_HQ_transcript/75394 | Identity 0.947 too low. | ddfcc741f95576745a92f2c7ad47dbdf | 358 | Pfam | PF18345 | Zinc finger domain | 167 | 185 | 4.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/75394|m.18918 | UnnamedSample_HQ_transcript/75394 | Identity 0.947 too low. | ddfcc741f95576745a92f2c7ad47dbdf | 358 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 236 | 289 | 1.6E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/67355|m.17463 | UnnamedSample_HQ_transcript/67355 | Identity 0.942 too low. | ddfcc741f95576745a92f2c7ad47dbdf | 358 | Pfam | PF18345 | Zinc finger domain | 167 | 185 | 4.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/67355|m.17463 | UnnamedSample_HQ_transcript/67355 | Identity 0.942 too low. | ddfcc741f95576745a92f2c7ad47dbdf | 358 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 236 | 289 | 1.6E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/3810|m.1741 | UnnamedSample_HQ_transcript/3810 | Identity 0.764 too low. | 08f68fe7551be083c8540d0ab47178ff | 139 | Pfam | PF03054 | tRNA methyl transferase | 2 | 136 | 2.2E-47 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7983|m.3176 | UnnamedSample_HQ_transcript/7983 | Unmapped. | 179ed71bcef7d19db7f26c940c0afd50 | 1277 | Pfam | PF01401 | Angiotensin-converting enzyme | 629 | 1206 | 1.4E-278 | T | 22-09-2020 | IPR001548 | Peptidase M2, peptidyl-dipeptidase A |
| UnnamedSample_HQ_transcript/7983|m.3176 | UnnamedSample_HQ_transcript/7983 | Unmapped. | 179ed71bcef7d19db7f26c940c0afd50 | 1277 | Pfam | PF01401 | Angiotensin-converting enzyme | 29 | 608 | 2.2E-269 | T | 22-09-2020 | IPR001548 | Peptidase M2, peptidyl-dipeptidase A |
| UnnamedSample_HQ_transcript/54628|m.14973 | UnnamedSample_HQ_transcript/54628 | Coverage 0.084 too low. | 33c474946157c78d9e70446b3920ab6c | 216 | Pfam | PF00261 | Tropomyosin | 2 | 184 | 7.3E-78 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/105804|m.23318 | UnnamedSample_HQ_transcript/105804 | Coverage 0.986 too low. | ab98a149f376d226c443a479eb91b438 | 144 | Pfam | PF00400 | WD domain, G-beta repeat | 12 | 58 | 3.1E-6 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/105804|m.23318 | UnnamedSample_HQ_transcript/105804 | Coverage 0.986 too low. | ab98a149f376d226c443a479eb91b438 | 144 | Pfam | PF00400 | WD domain, G-beta repeat | 62 | 100 | 6.2E-11 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/105804|m.23318 | UnnamedSample_HQ_transcript/105804 | Coverage 0.986 too low. | ab98a149f376d226c443a479eb91b438 | 144 | Pfam | PF00400 | WD domain, G-beta repeat | 104 | 139 | 0.046 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/102697|m.22953 | UnnamedSample_HQ_transcript/102697 | Coverage 0.948 too low. | 3891be5472c0162ae90b8487af5a7012 | 316 | Pfam | PF00685 | Sulfotransferase domain | 53 | 316 | 2.9E-64 | T | 22-09-2020 | IPR000863 | Sulfotransferase domain |
| UnnamedSample_HQ_transcript/82593|m.20132 | UnnamedSample_HQ_transcript/82593 | Coverage 0.315 too low. | 8d4c6171e6dcc064bded90fbc7fc4284 | 160 | Pfam | PF13639 | Ring finger domain | 9 | 57 | 1.3E-8 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/63861|m.16815 | UnnamedSample_HQ_transcript/63861 | Coverage 0.252 too low. | 8d4c6171e6dcc064bded90fbc7fc4284 | 160 | Pfam | PF13639 | Ring finger domain | 9 | 57 | 1.3E-8 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/58464|m.15740 | UnnamedSample_HQ_transcript/58464 | Coverage 0.908 too low. | 161bb8edbaa7248a7b909fba4ce26d08 | 649 | Pfam | PF00626 | Gelsolin repeat | 485 | 562 | 3.4E-14 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/58464|m.15740 | UnnamedSample_HQ_transcript/58464 | Coverage 0.908 too low. | 161bb8edbaa7248a7b909fba4ce26d08 | 649 | Pfam | PF13855 | Leucine rich repeat | 97 | 155 | 5.5E-9 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/58464|m.15740 | UnnamedSample_HQ_transcript/58464 | Coverage 0.908 too low. | 161bb8edbaa7248a7b909fba4ce26d08 | 649 | Pfam | PF13855 | Leucine rich repeat | 237 | 273 | 2.0E-6 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/58464|m.15740 | UnnamedSample_HQ_transcript/58464 | Coverage 0.908 too low. | 161bb8edbaa7248a7b909fba4ce26d08 | 649 | Pfam | PF13855 | Leucine rich repeat | 169 | 227 | 1.6E-6 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/58464|m.15740 | UnnamedSample_HQ_transcript/58464 | Coverage 0.908 too low. | 161bb8edbaa7248a7b909fba4ce26d08 | 649 | Pfam | PF13855 | Leucine rich repeat | 3 | 60 | 7.5E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/94708|m.21911 | UnnamedSample_HQ_transcript/94708 | Coverage 0.651 too low. | 1afcac5888475825dee86f8bb10f03b7 | 145 | Pfam | PF01395 | PBP/GOBP family | 29 | 112 | 1.2E-10 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/65965|m.17200 | UnnamedSample_HQ_transcript/65965 | Coverage 0.876 too low. | dbe7791fd8416751b189cfe0863ddd36 | 520 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 339 | 380 | 5.0E-7 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/65965|m.17200 | UnnamedSample_HQ_transcript/65965 | Coverage 0.876 too low. | dbe7791fd8416751b189cfe0863ddd36 | 520 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 295 | 334 | 1.5E-9 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/63388|m.16710 | UnnamedSample_HQ_transcript/63388 | Coverage 0.842 too low. | dbe7791fd8416751b189cfe0863ddd36 | 520 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 339 | 380 | 5.0E-7 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/63388|m.16710 | UnnamedSample_HQ_transcript/63388 | Coverage 0.842 too low. | dbe7791fd8416751b189cfe0863ddd36 | 520 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 295 | 334 | 1.5E-9 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/55679|m.15171 | UnnamedSample_HQ_transcript/55679 | Coverage 0.558 too low. | ae7126bf45b2961dd1f5354cebf794b1 | 633 | Pfam | PF13927 | Immunoglobulin domain | 537 | 619 | 4.3E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/55679|m.15171 | UnnamedSample_HQ_transcript/55679 | Coverage 0.558 too low. | ae7126bf45b2961dd1f5354cebf794b1 | 633 | Pfam | PF07679 | Immunoglobulin I-set domain | 402 | 491 | 1.9E-5 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/52485|m.14542 | UnnamedSample_HQ_transcript/52485 | Identity 0.866 too low. | be8877a5200582a6181c21aa3135dd7f | 610 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 5 | 41 | 1.8E-5 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/86430|m.20712 | UnnamedSample_HQ_transcript/86430 | Coverage 0.754 too low. | 37151cead8427ddc2eda6b03a66c59dd | 422 | Pfam | PF08512 | Histone chaperone Rttp106-like | 147 | 227 | 9.8E-19 | T | 22-09-2020 | IPR013719 | Domain of unknown function DUF1747 |
| UnnamedSample_HQ_transcript/80849|m.19849 | UnnamedSample_HQ_transcript/80849 | Coverage 0.798 too low. | 37151cead8427ddc2eda6b03a66c59dd | 422 | Pfam | PF08512 | Histone chaperone Rttp106-like | 147 | 227 | 9.8E-19 | T | 22-09-2020 | IPR013719 | Domain of unknown function DUF1747 |
| UnnamedSample_HQ_transcript/106822|m.23434 | UnnamedSample_HQ_transcript/106822 | Coverage 0.895 too low. | 3e6e443e0cd588dd8c4cf30bc3ccaddb | 250 | Pfam | PF00373 | FERM central domain | 118 | 223 | 2.4E-23 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/106822|m.23434 | UnnamedSample_HQ_transcript/106822 | Coverage 0.895 too low. | 3e6e443e0cd588dd8c4cf30bc3ccaddb | 250 | Pfam | PF09379 | FERM N-terminal domain | 38 | 100 | 1.0E-18 | T | 22-09-2020 | IPR018979 | FERM, N-terminal |
| UnnamedSample_HQ_transcript/43426|m.12586 | UnnamedSample_HQ_transcript/43426 | Identity 0.881 too low. | 3fa5ce5eaa26b536c40e37e8fe672e57 | 610 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 5 | 41 | 1.8E-5 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/105166|m.23249 | UnnamedSample_HQ_transcript/105166 | Coverage 0.578 too low. | 34f789941c861b42fd2ea0f5f0fd71cd | 230 | Pfam | PF00261 | Tropomyosin | 16 | 203 | 7.2E-70 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/61438|m.16344 | UnnamedSample_HQ_transcript/61438 | Coverage 0.921 too low. | 61497c085692f4fcec427bd3966cadcd | 297 | Pfam | PF13894 | C2H2-type zinc finger | 67 | 89 | 2.9E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/61438|m.16344 | UnnamedSample_HQ_transcript/61438 | Coverage 0.921 too low. | 61497c085692f4fcec427bd3966cadcd | 297 | Pfam | PF00096 | Zinc finger, C2H2 type | 95 | 117 | 2.3E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/61438|m.16344 | UnnamedSample_HQ_transcript/61438 | Coverage 0.921 too low. | 61497c085692f4fcec427bd3966cadcd | 297 | Pfam | PF00096 | Zinc finger, C2H2 type | 123 | 145 | 6.8E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/61438|m.16344 | UnnamedSample_HQ_transcript/61438 | Coverage 0.921 too low. | 61497c085692f4fcec427bd3966cadcd | 297 | Pfam | PF00096 | Zinc finger, C2H2 type | 39 | 61 | 1.4E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/37550|m.11290 | UnnamedSample_HQ_transcript/37550 | Identity 0.866 too low. | c086af6eabb08f2c7bf82e1218d89ed1 | 751 | Pfam | PF01480 | PWI domain | 43 | 114 | 1.5E-30 | T | 22-09-2020 | IPR002483 | PWI domain |
| UnnamedSample_HQ_transcript/89739|m.21202 | UnnamedSample_HQ_transcript/89739 | Coverage 0.131 too low. | 07a03399fd44f171cf0e17b361923f24 | 191 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 1 | 165 | 3.3E-38 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/94521|m.21879 | UnnamedSample_HQ_transcript/94521 | Coverage 0.071 too low. | 07a03399fd44f171cf0e17b361923f24 | 191 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 1 | 165 | 3.3E-38 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/3091|m.1476 | UnnamedSample_HQ_transcript/3091 | Identity 0.895 too low. | 7c6795243c8e982b1e3d942ae9877e3f | 1417 | Pfam | PF11502 | B-cell lymphoma 9 protein | 441 | 477 | 5.5E-6 | T | 22-09-2020 | IPR024670 | B-cell lymphoma 9, beta-catenin binding domain |
| UnnamedSample_HQ_transcript/66861|m.17379 | UnnamedSample_HQ_transcript/66861 | Coverage 0.178 too low. | b43b6a9a1413cccdf10a857ae723e5ed | 507 | Pfam | PF00067 | Cytochrome P450 | 41 | 503 | 9.5E-114 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/32196|m.9999 | UnnamedSample_HQ_transcript/32196 | Unmapped. | 596a996b1563d25c36dbdbf5dab1966b | 804 | Pfam | PF13086 | AAA domain | 665 | 737 | 2.9E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/32196|m.9999 | UnnamedSample_HQ_transcript/32196 | Unmapped. | 596a996b1563d25c36dbdbf5dab1966b | 804 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 265 | 2.2E-6 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/111475|m.24018 | UnnamedSample_HQ_transcript/111475 | Coverage 0.528 too low. | eb25d38de948a3666b0f2c90bcdbae2f | 205 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 74 | 175 | 3.8E-26 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/66314|m.17271 | UnnamedSample_HQ_transcript/66314 | Coverage 0.204 too low. | f24dddb273371841181a8d5752cb944b | 234 | Pfam | PF00501 | AMP-binding enzyme | 6 | 100 | 9.8E-25 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/48498|m.13695 | UnnamedSample_HQ_transcript/48498 | Coverage 0.210 too low. | f24dddb273371841181a8d5752cb944b | 234 | Pfam | PF00501 | AMP-binding enzyme | 6 | 100 | 9.8E-25 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/57641|m.15577 | UnnamedSample_HQ_transcript/57641 | Coverage 0.161 too low. | f24dddb273371841181a8d5752cb944b | 234 | Pfam | PF00501 | AMP-binding enzyme | 6 | 100 | 9.8E-25 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/21598|m.7307 | UnnamedSample_HQ_transcript/21598 | Coverage 0.097 too low. | 761642865de72dd53d1b8d767cfb4512 | 766 | Pfam | PF13927 | Immunoglobulin domain | 419 | 500 | 2.9E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21598|m.7307 | UnnamedSample_HQ_transcript/21598 | Coverage 0.097 too low. | 761642865de72dd53d1b8d767cfb4512 | 766 | Pfam | PF13927 | Immunoglobulin domain | 256 | 318 | 2.1E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21598|m.7307 | UnnamedSample_HQ_transcript/21598 | Coverage 0.097 too low. | 761642865de72dd53d1b8d767cfb4512 | 766 | Pfam | PF13927 | Immunoglobulin domain | 335 | 399 | 3.9E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21598|m.7307 | UnnamedSample_HQ_transcript/21598 | Coverage 0.097 too low. | 761642865de72dd53d1b8d767cfb4512 | 766 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 136 | 224 | 3.0E-16 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/21598|m.7307 | UnnamedSample_HQ_transcript/21598 | Coverage 0.097 too low. | 761642865de72dd53d1b8d767cfb4512 | 766 | Pfam | PF07679 | Immunoglobulin I-set domain | 30 | 110 | 2.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/86531|m.20724 | UnnamedSample_HQ_transcript/86531 | Coverage 0.989 too low. | 45908a6743e89ba80ea03fa4d559499e | 263 | Pfam | PF13855 | Leucine rich repeat | 98 | 157 | 3.2E-11 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/86531|m.20724 | UnnamedSample_HQ_transcript/86531 | Coverage 0.989 too low. | 45908a6743e89ba80ea03fa4d559499e | 263 | Pfam | PF13855 | Leucine rich repeat | 2 | 58 | 1.6E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/12813|m.4760 | UnnamedSample_HQ_transcript/12813 | Identity 0.919 too low. | 049f245944d7f0aed3e2c4665916d627 | 1211 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 47 | 110 | 2.4E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/12813|m.4760 | UnnamedSample_HQ_transcript/12813 | Identity 0.919 too low. | 049f245944d7f0aed3e2c4665916d627 | 1211 | Pfam | PF00567 | Tudor domain | 639 | 749 | 2.7E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/12813|m.4760 | UnnamedSample_HQ_transcript/12813 | Identity 0.919 too low. | 049f245944d7f0aed3e2c4665916d627 | 1211 | Pfam | PF00567 | Tudor domain | 1048 | 1129 | 8.3E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/12813|m.4760 | UnnamedSample_HQ_transcript/12813 | Identity 0.919 too low. | 049f245944d7f0aed3e2c4665916d627 | 1211 | Pfam | PF00567 | Tudor domain | 846 | 954 | 1.2E-13 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/74464|m.18737 | UnnamedSample_HQ_transcript/74464 | Coverage 0.952 too low. | ea1c7151c9b72288833fbac6b91c51d3 | 510 | Pfam | PF08699 | Argonaute linker 1 domain | 392 | 438 | 2.1E-11 | T | 22-09-2020 | IPR014811 | Argonaute, linker 1 domain |
| UnnamedSample_HQ_transcript/74464|m.18737 | UnnamedSample_HQ_transcript/74464 | Coverage 0.952 too low. | ea1c7151c9b72288833fbac6b91c51d3 | 510 | Pfam | PF16486 | N-terminal domain of argonaute | 246 | 379 | 8.9E-17 | T | 22-09-2020 | IPR032474 | Protein argonaute, N-terminal |
| UnnamedSample_HQ_transcript/94826|m.21929 | UnnamedSample_HQ_transcript/94826 | Coverage 0.988 too low. | 8ac2b876a5c24da731580f669451f7a6 | 136 | Pfam | PF01151 | GNS1/SUR4 family | 2 | 101 | 2.4E-18 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/29228|m.9284 | UnnamedSample_HQ_transcript/29228 | Coverage 0.036 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/27908|m.8945 | UnnamedSample_HQ_transcript/27908 | Coverage 0.047 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/26274|m.8548 | UnnamedSample_HQ_transcript/26274 | Coverage 0.075 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/17432|m.6134 | UnnamedSample_HQ_transcript/17432 | Coverage 0.053 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/74413|m.18727 | UnnamedSample_HQ_transcript/74413 | Coverage 0.861 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/84928|m.20489 | UnnamedSample_HQ_transcript/84928 | Coverage 0.167 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/24607|m.8107 | UnnamedSample_HQ_transcript/24607 | Coverage 0.091 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/24547|m.8084 | UnnamedSample_HQ_transcript/24547 | Coverage 0.058 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/31312|m.9792 | UnnamedSample_HQ_transcript/31312 | Coverage 0.930 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/20576|m.7027 | UnnamedSample_HQ_transcript/20576 | Coverage 0.157 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/28650|m.9128 | UnnamedSample_HQ_transcript/28650 | Coverage 0.062 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/10337|m.3938 | UnnamedSample_HQ_transcript/10337 | Coverage 0.326 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/26365|m.8568 | UnnamedSample_HQ_transcript/26365 | Coverage 0.063 too low. | 2b1ccb846b8ab59d09625bd75c16c41f | 362 | Pfam | PF01151 | GNS1/SUR4 family | 27 | 261 | 1.2E-62 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/89862|m.21231 | UnnamedSample_HQ_transcript/89862 | Coverage 0.507 too low. | 037b59ddbcaf769d83c55094fb2022ff | 243 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 4.8E-71 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/83615|m.20282 | UnnamedSample_HQ_transcript/83615 | Coverage 0.989 too low. | ce23e8ccb4f7b83d433e79e0db8fb6ca | 399 | Pfam | PF00380 | Ribosomal protein S9/S16 | 279 | 399 | 1.8E-25 | T | 22-09-2020 | IPR000754 | Ribosomal protein S9 |
| UnnamedSample_HQ_transcript/14165|m.5160 | UnnamedSample_HQ_transcript/14165 | Identity 0.941 too low. | 50bbee79c7bee53fc9ed7f57c2f3ce80 | 350 | Pfam | PF02879 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain II | 205 | 298 | 9.5E-17 | T | 22-09-2020 | IPR005845 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain II |
| UnnamedSample_HQ_transcript/14165|m.5160 | UnnamedSample_HQ_transcript/14165 | Identity 0.941 too low. | 50bbee79c7bee53fc9ed7f57c2f3ce80 | 350 | Pfam | PF02878 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain I | 16 | 156 | 4.7E-36 | T | 22-09-2020 | IPR005844 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain I |
| UnnamedSample_HQ_transcript/32830|m.10174 | UnnamedSample_HQ_transcript/32830 | Coverage 0.919 too low. | 098d87ca2d851a8b56f849bac3e4e9da | 883 | Pfam | PF02210 | Laminin G domain | 198 | 318 | 1.1E-24 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/32830|m.10174 | UnnamedSample_HQ_transcript/32830 | Coverage 0.919 too low. | 098d87ca2d851a8b56f849bac3e4e9da | 883 | Pfam | PF02210 | Laminin G domain | 809 | 882 | 4.7E-10 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/32830|m.10174 | UnnamedSample_HQ_transcript/32830 | Coverage 0.919 too low. | 098d87ca2d851a8b56f849bac3e4e9da | 883 | Pfam | PF02210 | Laminin G domain | 383 | 501 | 1.0E-15 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/32830|m.10174 | UnnamedSample_HQ_transcript/32830 | Coverage 0.919 too low. | 098d87ca2d851a8b56f849bac3e4e9da | 883 | Pfam | PF00008 | EGF-like domain | 531 | 560 | 7.2E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/32830|m.10174 | UnnamedSample_HQ_transcript/32830 | Coverage 0.919 too low. | 098d87ca2d851a8b56f849bac3e4e9da | 883 | Pfam | PF00754 | F5/8 type C domain | 34 | 159 | 3.6E-22 | T | 22-09-2020 | IPR000421 | Coagulation factor 5/8 C-terminal domain |
| UnnamedSample_HQ_transcript/58953|m.15841 | UnnamedSample_HQ_transcript/58953 | Coverage 0.526 too low. | b9fa02ac6cedd098102199257968c7d4 | 543 | Pfam | PF00849 | RNA pseudouridylate synthase | 245 | 393 | 1.2E-29 | T | 22-09-2020 | IPR006145 | Pseudouridine synthase, RsuA/RluA |
| UnnamedSample_HQ_transcript/63361|m.16703 | UnnamedSample_HQ_transcript/63361 | Coverage 0.519 too low. | a7d11326eb38b63774b22900bb702fb6 | 531 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 128 | 509 | 1.2E-93 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/27488|m.8828 | UnnamedSample_HQ_transcript/27488 | Coverage 0.145 too low. | 489d12459de72e30b3b22b835cd8ae40 | 329 | Pfam | PF00069 | Protein kinase domain | 94 | 297 | 5.7E-66 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/57418|m.15528 | UnnamedSample_HQ_transcript/57418 | Unmapped. | 7a728ff648727262f5d1892479c97b2b | 537 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 523 | 5.3E-89 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/74425|m.18729 | UnnamedSample_HQ_transcript/74425 | Coverage 0.132 too low. | fd643976c20df0150beabe86db5715fc | 207 | Pfam | PF00046 | Homeodomain | 4 | 32 | 1.8E-10 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/111383|m.24008 | UnnamedSample_HQ_transcript/111383 | Coverage 0.953 too low. | 6d91a3356119a17634df78bb70e76371 | 178 | Pfam | PF01775 | Ribosomal proteins 50S-L18Ae/60S-L20/60S-L18A | 7 | 130 | 2.4E-54 | T | 22-09-2020 | IPR023573 | Ribosomal protein 50S-L18Ae/60S-L20/60S-L18A |
| UnnamedSample_HQ_transcript/42608|m.12395 | UnnamedSample_HQ_transcript/42608 | Coverage 0.778 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 205 | 294 | 1.8E-15 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/42608|m.12395 | UnnamedSample_HQ_transcript/42608 | Coverage 0.778 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 13 | 136 | 3.4E-28 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/78188|m.19407 | UnnamedSample_HQ_transcript/78188 | Coverage 0.823 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 205 | 294 | 1.8E-15 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/78188|m.19407 | UnnamedSample_HQ_transcript/78188 | Coverage 0.823 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 13 | 136 | 3.4E-28 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/52630|m.14571 | UnnamedSample_HQ_transcript/52630 | Coverage 0.874 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 205 | 294 | 1.8E-15 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/52630|m.14571 | UnnamedSample_HQ_transcript/52630 | Coverage 0.874 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 13 | 136 | 3.4E-28 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/46944|m.13350 | UnnamedSample_HQ_transcript/46944 | Coverage 0.829 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 205 | 294 | 1.8E-15 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/46944|m.13350 | UnnamedSample_HQ_transcript/46944 | Coverage 0.829 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 13 | 136 | 3.4E-28 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/74126|m.18670 | UnnamedSample_HQ_transcript/74126 | Coverage 0.773 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 205 | 294 | 1.8E-15 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/74126|m.18670 | UnnamedSample_HQ_transcript/74126 | Coverage 0.773 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 13 | 136 | 3.4E-28 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/71869|m.18280 | UnnamedSample_HQ_transcript/71869 | Coverage 0.764 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 205 | 294 | 1.8E-15 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/71869|m.18280 | UnnamedSample_HQ_transcript/71869 | Coverage 0.764 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 13 | 136 | 3.4E-28 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/67720|m.17529 | UnnamedSample_HQ_transcript/67720 | Coverage 0.684 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 205 | 294 | 1.8E-15 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/67720|m.17529 | UnnamedSample_HQ_transcript/67720 | Coverage 0.684 too low. | 701185a7afcb3aed088c5eafe9492de3 | 373 | Pfam | PF01467 | Cytidylyltransferase-like | 13 | 136 | 3.4E-28 | T | 22-09-2020 | IPR004821 | Cytidyltransferase-like domain |
| UnnamedSample_HQ_transcript/7698|m.3088 | UnnamedSample_HQ_transcript/7698 | Coverage 0.636 too low. | 56ba5570a48f34e6265a67d300d6eafc | 618 | Pfam | PF00652 | Ricin-type beta-trefoil lectin domain | 489 | 605 | 6.1E-27 | T | 22-09-2020 | IPR000772 | Ricin B, lectin domain |
| UnnamedSample_HQ_transcript/7698|m.3088 | UnnamedSample_HQ_transcript/7698 | Coverage 0.636 too low. | 56ba5570a48f34e6265a67d300d6eafc | 618 | Pfam | PF00535 | Glycosyl transferase family 2 | 179 | 361 | 1.0E-34 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/62773|m.16591 | UnnamedSample_HQ_transcript/62773 | Coverage 0.889 too low. | 468aa5070e1ec503bec2fdb8586ae573 | 415 | Pfam | PF04503 | Single-stranded DNA binding protein, SSDP | 136 | 363 | 2.5E-59 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/62773|m.16591 | UnnamedSample_HQ_transcript/62773 | Coverage 0.889 too low. | 468aa5070e1ec503bec2fdb8586ae573 | 415 | Pfam | PF04503 | Single-stranded DNA binding protein, SSDP | 81 | 135 | 8.2E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/62|m.62 | UnnamedSample_HQ_transcript/62 | Unmapped. | 56715430fd3b0dc0c4f4cf1e583e731d | 3117 | Pfam | PF08762 | CRPV capsid protein like | 1065 | 1275 | 2.1E-11 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/62|m.62 | UnnamedSample_HQ_transcript/62 | Unmapped. | 56715430fd3b0dc0c4f4cf1e583e731d | 3117 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 2751 | 3076 | 6.4E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/62|m.62 | UnnamedSample_HQ_transcript/62 | Unmapped. | 56715430fd3b0dc0c4f4cf1e583e731d | 3117 | Pfam | PF00910 | RNA helicase | 1689 | 1797 | 1.3E-17 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/53634|m.14770 | UnnamedSample_HQ_transcript/53634 | Coverage 0.482 too low. | a0fc34053a1906daa801a606a2f30846 | 514 | Pfam | PF00083 | Sugar (and other) transporter | 106 | 496 | 1.3E-32 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/58777|m.15809 | UnnamedSample_HQ_transcript/58777 | Coverage 0.911 too low. | ae505513bc591155ae06fa396d6ba6d8 | 455 | Pfam | PF01594 | AI-2E family transporter | 184 | 433 | 7.0E-9 | T | 22-09-2020 | IPR002549 | Transmembrane protein TqsA-like |
| UnnamedSample_HQ_transcript/95712|m.22052 | UnnamedSample_HQ_transcript/95712 | Coverage 0.907 too low. | fc6437e59984e3f5be8390eb63addd4b | 331 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 318 | 4.7E-119 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/82975|m.20195 | UnnamedSample_HQ_transcript/82975 | Unmapped. | ff5560f13d5ffc5d9ddbbefa2fc792c2 | 493 | Pfam | PF13086 | AAA domain | 401 | 466 | 2.2E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/16387|m.5824 | UnnamedSample_HQ_transcript/16387 | Coverage 0.184 too low. | 728e9a8e347656b89950fbe06338293f | 1000 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 612 | 733 | 3.6E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/16387|m.5824 | UnnamedSample_HQ_transcript/16387 | Coverage 0.184 too low. | 728e9a8e347656b89950fbe06338293f | 1000 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 3 | 572 | 3.3E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/25864|m.8440 | UnnamedSample_HQ_transcript/25864 | Coverage 0.739 too low. | 9e8f51e0fb0c4acdd038b990ca2bc796 | 876 | Pfam | PF00093 | von Willebrand factor type C domain | 739 | 792 | 5.6E-9 | T | 22-09-2020 | IPR001007 | VWFC domain |
| UnnamedSample_HQ_transcript/25864|m.8440 | UnnamedSample_HQ_transcript/25864 | Coverage 0.739 too low. | 9e8f51e0fb0c4acdd038b990ca2bc796 | 876 | Pfam | PF00093 | von Willebrand factor type C domain | 606 | 657 | 2.6E-9 | T | 22-09-2020 | IPR001007 | VWFC domain |
| UnnamedSample_HQ_transcript/25864|m.8440 | UnnamedSample_HQ_transcript/25864 | Coverage 0.739 too low. | 9e8f51e0fb0c4acdd038b990ca2bc796 | 876 | Pfam | PF02822 | Antistasin family | 458 | 484 | 2.1E-7 | T | 22-09-2020 | IPR004094 | Antistasin-like domain |
| UnnamedSample_HQ_transcript/25864|m.8440 | UnnamedSample_HQ_transcript/25864 | Coverage 0.739 too low. | 9e8f51e0fb0c4acdd038b990ca2bc796 | 876 | Pfam | PF00219 | Insulin-like growth factor binding protein | 37 | 92 | 4.8E-8 | T | 22-09-2020 | IPR000867 | Insulin-like growth factor-binding protein, IGFBP |
| UnnamedSample_HQ_transcript/38613|m.11532 | UnnamedSample_HQ_transcript/38613 | Coverage 0.309 too low. | 7580577bc2fad7d7f1c65bb68a9c1b38 | 522 | Pfam | PF01130 | CD36 family | 424 | 514 | 3.3E-16 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/38613|m.11532 | UnnamedSample_HQ_transcript/38613 | Coverage 0.309 too low. | 7580577bc2fad7d7f1c65bb68a9c1b38 | 522 | Pfam | PF01130 | CD36 family | 92 | 381 | 4.3E-57 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/36092|m.10955 | UnnamedSample_HQ_transcript/36092 | Coverage 0.210 too low. | 1c579e30a3be93417cdf308794869b0f | 284 | Pfam | PF00505 | HMG (high mobility group) box | 1 | 61 | 9.1E-16 | T | 22-09-2020 | IPR009071 | High mobility group box domain |
| UnnamedSample_HQ_transcript/97565|m.22310 | UnnamedSample_HQ_transcript/97565 | Coverage 0.847 too low. | 6268fc08e7ae2d93eac81a5fb5211e90 | 360 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 28 | 89 | 1.3E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/97565|m.22310 | UnnamedSample_HQ_transcript/97565 | Coverage 0.847 too low. | 6268fc08e7ae2d93eac81a5fb5211e90 | 360 | Pfam | PF00107 | Zinc-binding dehydrogenase | 151 | 280 | 9.1E-14 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/51411|m.14335 | UnnamedSample_HQ_transcript/51411 | Coverage 0.586 too low. | 53d6a9ca4ee659f4df2a0058cfcda6e4 | 458 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.6E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/79807|m.19675 | UnnamedSample_HQ_transcript/79807 | Identity 0.948 too low. | 22290f00c33f73aa847bdd2e3f5b4832 | 504 | Pfam | PF12455 | Dynein associated protein | 8 | 262 | 4.8E-76 | T | 22-09-2020 | IPR022157 | Dynein associated protein |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00307 | Calponin homology (CH) domain | 169 | 273 | 3.4E-26 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00307 | Calponin homology (CH) domain | 49 | 152 | 1.2E-19 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1594 | 1696 | 8.4E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1699 | 1801 | 5.6E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 419 | 520 | 1.3E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1806 | 1908 | 6.7E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 742 | 843 | 1.4E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 2019 | 2106 | 4.8E-11 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1386 | 1483 | 1.1E-15 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1060 | 1166 | 6.7E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 636 | 738 | 6.4E-25 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 524 | 633 | 8.6E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1912 | 2014 | 2.5E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 954 | 1057 | 5.7E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1276 | 1376 | 2.1E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1170 | 1266 | 2.8E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 1487 | 1589 | 1.1E-20 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 848 | 949 | 1.6E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF00435 | Spectrin repeat | 299 | 407 | 3.8E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/227|m.198 | UnnamedSample_HQ_transcript/227 | Coverage 0.960 too low. | cea09c9a5961234833594bd5b503cd42 | 2357 | Pfam | PF15410 | Pleckstrin homology domain | 2213 | 2317 | 3.2E-15 | T | 22-09-2020 | IPR041681 | Pleckstrin homology domain 9 |
| UnnamedSample_HQ_transcript/34172|m.10514 | UnnamedSample_HQ_transcript/34172 | Identity 0.935 too low. | 8d7ed315420b52ad56bd4e8539630591 | 693 | Pfam | PF08416 | Phosphotyrosine-binding domain | 26 | 147 | 1.3E-16 | T | 22-09-2020 | IPR013625 | Tensin/EPS8 phosphotyrosine-binding domain |
| UnnamedSample_HQ_transcript/23635|m.7846 | UnnamedSample_HQ_transcript/23635 | Identity 0.943 too low. | 8d7ed315420b52ad56bd4e8539630591 | 693 | Pfam | PF08416 | Phosphotyrosine-binding domain | 26 | 147 | 1.3E-16 | T | 22-09-2020 | IPR013625 | Tensin/EPS8 phosphotyrosine-binding domain |
| UnnamedSample_HQ_transcript/11843|m.4442 | UnnamedSample_HQ_transcript/11843 | Identity 0.846 too low. | 5f5a2bac9f64ba56333694e92596d7e1 | 992 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 669 | 926 | 1.5E-114 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/27392|m.8809 | UnnamedSample_HQ_transcript/27392 | Coverage 0.230 too low. | 92660d6b1a3af1651d6ac2f8413d38e6 | 818 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 430 | 551 | 2.6E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/27392|m.8809 | UnnamedSample_HQ_transcript/27392 | Coverage 0.230 too low. | 92660d6b1a3af1651d6ac2f8413d38e6 | 818 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 15 | 390 | 4.4E-10 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/69013|m.17763 | UnnamedSample_HQ_transcript/69013 | Identity 0.908 too low. | 92d307d5e6db201af322f62ba5245f70 | 149 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 3 | 129 | 3.2E-32 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/61776|m.16401 | UnnamedSample_HQ_transcript/61776 | Coverage 0.880 too low. | d037c1c511ca50d885cd6e5334ea8d4b | 636 | Pfam | PF00176 | SNF2 family N-terminal domain | 1 | 257 | 3.2E-59 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/61776|m.16401 | UnnamedSample_HQ_transcript/61776 | Coverage 0.880 too low. | d037c1c511ca50d885cd6e5334ea8d4b | 636 | Pfam | PF00271 | Helicase conserved C-terminal domain | 284 | 396 | 3.4E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/57345|m.15512 | UnnamedSample_HQ_transcript/57345 | Coverage 0.883 too low. | f2253d1f2e0261af2dd90eaf098e4716 | 595 | Pfam | PF17862 | AAA+ lid domain | 305 | 342 | 3.4E-13 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/57345|m.15512 | UnnamedSample_HQ_transcript/57345 | Coverage 0.883 too low. | f2253d1f2e0261af2dd90eaf098e4716 | 595 | Pfam | PF01434 | Peptidase family M41 | 358 | 539 | 3.8E-66 | T | 22-09-2020 | IPR000642 | Peptidase M41 |
| UnnamedSample_HQ_transcript/57345|m.15512 | UnnamedSample_HQ_transcript/57345 | Coverage 0.883 too low. | f2253d1f2e0261af2dd90eaf098e4716 | 595 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 143 | 274 | 2.0E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/109915|m.23821 | UnnamedSample_HQ_transcript/109915 | Unmapped. | 282850218de89e361710f35e7239274a | 224 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 1 | 222 | 1.0E-29 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/85676|m.20593 | UnnamedSample_HQ_transcript/85676 | Coverage 0.785 too low. | c9aa49352ea99703576aa1eb8e0df9d2 | 376 | Pfam | PF00348 | Polyprenyl synthetase | 57 | 315 | 4.7E-23 | T | 22-09-2020 | IPR000092 | Polyprenyl synthetase |
| UnnamedSample_HQ_transcript/90248|m.21288 | UnnamedSample_HQ_transcript/90248 | Coverage 0.780 too low. | c9aa49352ea99703576aa1eb8e0df9d2 | 376 | Pfam | PF00348 | Polyprenyl synthetase | 57 | 315 | 4.7E-23 | T | 22-09-2020 | IPR000092 | Polyprenyl synthetase |
| UnnamedSample_HQ_transcript/94920|m.21946 | UnnamedSample_HQ_transcript/94920 | Coverage 0.837 too low. | c9aa49352ea99703576aa1eb8e0df9d2 | 376 | Pfam | PF00348 | Polyprenyl synthetase | 57 | 315 | 4.7E-23 | T | 22-09-2020 | IPR000092 | Polyprenyl synthetase |
| UnnamedSample_HQ_transcript/94712|m.21912 | UnnamedSample_HQ_transcript/94712 | Coverage 0.759 too low. | c9aa49352ea99703576aa1eb8e0df9d2 | 376 | Pfam | PF00348 | Polyprenyl synthetase | 57 | 315 | 4.7E-23 | T | 22-09-2020 | IPR000092 | Polyprenyl synthetase |
| UnnamedSample_HQ_transcript/88519|m.21022 | UnnamedSample_HQ_transcript/88519 | Coverage 0.835 too low. | c9aa49352ea99703576aa1eb8e0df9d2 | 376 | Pfam | PF00348 | Polyprenyl synthetase | 57 | 315 | 4.7E-23 | T | 22-09-2020 | IPR000092 | Polyprenyl synthetase |
| UnnamedSample_HQ_transcript/109242|m.23744 | UnnamedSample_HQ_transcript/109242 | Unmapped. | 95d1362485e01b6e9f99eba67ef69008 | 252 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 96 | 166 | 1.1E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/24826|m.8175 | UnnamedSample_HQ_transcript/24826 | Coverage 0.903 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/42983|m.12478 | UnnamedSample_HQ_transcript/42983 | Coverage 0.849 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/46700|m.13299 | UnnamedSample_HQ_transcript/46700 | Coverage 0.806 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/33299|m.10286 | UnnamedSample_HQ_transcript/33299 | Coverage 0.882 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/60693|m.16196 | UnnamedSample_HQ_transcript/60693 | Coverage 0.823 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/66117|m.17234 | UnnamedSample_HQ_transcript/66117 | Coverage 0.827 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/23145|m.7726 | UnnamedSample_HQ_transcript/23145 | Coverage 0.897 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/26167|m.8521 | UnnamedSample_HQ_transcript/26167 | Coverage 0.924 too low. | 6d490af871eee38141c6c026de9b8d03 | 490 | Pfam | PF09790 | Hyccin | 25 | 353 | 3.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
